search icon
qntm-img

Quantum BioPharma Ltd., Common Stock

QNTM

NAQ

$3.28

-$0.1

(-2.96%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$6.30M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
38.87K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.85
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.7 L
$70.85 H
$3.28

About Quantum BioPharma Ltd., Common Stock

Quantum BioPharma Ltd., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd., is headquartered in Toronto, Canada. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameQNTMSectorS&P500
1-Week Return-15.68%0.31%-1.26%
1-Month Return-20.96%0.6%-4.16%
3-Month Return-31.95%-9.44%-0.46%
6-Month Return-64.96%-5.15%3.58%
1-Year Return-94.46%0.33%22.47%
3-Year Return-95.1%4.53%25.13%
5-Year Return-99.13%35.98%77.7%
10-Year Return-99.71%100.72%190.12%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue2.04M----[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit(1.84M)----[{"date":"2019-12-31","value":-184265121,"profit":false},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses-30.60M33.74M27.43M19.57M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":90.69,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":81.29,"profit":true},{"date":"2023-12-31","value":58,"profit":true}]
Operating Income-(30.60M)(33.74M)(27.43M)(19.57M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-3060122800,"profit":false},{"date":"2021-12-31","value":-3374366000,"profit":false},{"date":"2022-12-31","value":-2742961100,"profit":false},{"date":"2023-12-31","value":-1957011400,"profit":false}]
Total Non-Operating Income/Expense-2.15M(194.30K)725.95K1.34M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-9.04,"profit":false},{"date":"2022-12-31","value":33.78,"profit":true},{"date":"2023-12-31","value":62.33,"profit":true}]
Pre-Tax Income-(28.45M)(33.94M)(26.70M)(18.23M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-2845223200,"profit":false},{"date":"2021-12-31","value":-3393795600,"profit":false},{"date":"2022-12-31","value":-2670366200,"profit":false},{"date":"2023-12-31","value":-1823058800,"profit":false}]
Income Taxes-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations-(28.45M)(33.94M)(26.70M)(18.23M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-2845223200,"profit":false},{"date":"2021-12-31","value":-3393795600,"profit":false},{"date":"2022-12-31","value":-2670366200,"profit":false},{"date":"2023-12-31","value":-1823058800,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income-(31.80M)(35.29M)(23.61M)(17.90M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-3179979300,"profit":false},{"date":"2021-12-31","value":-3528542900,"profit":false},{"date":"2022-12-31","value":-2360682800,"profit":false},{"date":"2023-12-31","value":-1790217900,"profit":false}]
EPS (Diluted)(340.58)(189.74)--(124.85)[{"date":"2019-12-31","value":-34057.81,"profit":false},{"date":"2020-12-31","value":-18973.83,"profit":false},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-12484.69,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

QNTM
Current Ratio 3.76

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

QNTM
ROA (LTM) -36.12%
ROE (LTM) -63.89%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

QNTM
Debt Ratio Lower is generally better. Negative is bad. 0.19
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.86

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

QNTM
Trailing PE NM
Forward PE NM
P/S (TTM) 91.86
P/B 0.55
Price/FCF NM
EV/R 98.56
EV/Ebitda NM

FAQs

What is Quantum BioPharma Ltd. share price today?

Quantum BioPharma Ltd. (QNTM) share price today is $3.28

Can Indians buy Quantum BioPharma Ltd. shares?

Yes, Indians can buy shares of Quantum BioPharma Ltd. (QNTM) on Vested. To buy Quantum BioPharma Ltd. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in QNTM stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Quantum BioPharma Ltd. be purchased?

Yes, you can purchase fractional shares of Quantum BioPharma Ltd. (QNTM) via the Vested app. You can start investing in Quantum BioPharma Ltd. (QNTM) with a minimum investment of $1.

How to invest in Quantum BioPharma Ltd. shares from India?

You can invest in shares of Quantum BioPharma Ltd. (QNTM) via Vested in three simple steps:

  • Click on Sign Up or Invest in QNTM stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Quantum BioPharma Ltd. shares
What is Quantum BioPharma Ltd. 52-week high and low stock price?

The 52-week high price of Quantum BioPharma Ltd. (QNTM) is $70.85. The 52-week low price of Quantum BioPharma Ltd. (QNTM) is $2.7.

What is Quantum BioPharma Ltd. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Quantum BioPharma Ltd. (QNTM) is

What is Quantum BioPharma Ltd. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Quantum BioPharma Ltd. (QNTM) is 0.55

What is Quantum BioPharma Ltd. dividend yield?

The dividend yield of Quantum BioPharma Ltd. (QNTM) is 0.00%

What is the Market Cap of Quantum BioPharma Ltd.?

The market capitalization of Quantum BioPharma Ltd. (QNTM) is $6.30M

What is Quantum BioPharma Ltd.’s stock symbol?

The stock symbol (or ticker) of Quantum BioPharma Ltd. is QNTM

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top